Mega Patch was founded in 2015 by a team of healthcare professionals and innovators who recognized the need for more efficient and effective ways to deliver medication and nutrients. The concept originated during a healthcare conference where discussions about patient compliance and the challenges of traditional medication delivery methods highlighted a gap in the market. This led the founders to explore transdermal technology, which utilizes patches to administer therapeutic agents through the skin.
In its early stages, Mega Patch focused on research and development, collaborating with pharmaceutical scientists to develop patches that would provide a steady release of medications over extended periods. By 2017, the company introduced its first product, a nicotine replacement patch designed to aid smokers in their efforts to quit. This product marked the beginning of Mega Patch’s expansion into various therapeutic areas, including pain management and hormonal therapy.
From 2018 onward, Mega Patch began to diversify its product lineup, launching patches for pain relief, vitamin supplementation, and allergy relief. The brand gained recognition in the healthcare industry for its innovative approach to transdermal delivery, leading to partnerships with healthcare providers and pharmacies.
In 2020, Mega Patch expanded its reach internationally, entering markets in Europe and Asia, where demand for alternative medication delivery methods was on the rise. The brand invested in advanced manufacturing technology to ensure high-quality production standards and compliance with international regulations.
Today, Mega Patch continues to evolve, focusing on research and innovation to develop new products that meet the changing needs of consumers. With a commitment to improving patient outcomes through convenience and efficacy, Mega Patch has established itself as a leader in the transdermal patch segment of the healthcare industry.
Browse top picks
Open the official store and see current availability.